Compare · ILMN vs TRUP
ILMN vs TRUP
Side-by-side comparison of Illumina Inc. (ILMN) and Trupanion Inc. (TRUP): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ILMN and TRUP operate in Medical Specialities (Health Care), so they compete in similar markets.
- ILMN is the larger of the two at $41.04B, about 35.0x TRUP ($1.17B).
- Over the past year, ILMN is up 172.5% and TRUP is down 33.5% - ILMN leads by 206.0 points.
- ILMN has been more active in the news (8 items in the past 4 weeks vs 4 for TRUP).
- ILMN has more recent analyst coverage (25 ratings vs 13 for TRUP).
- Company
- Illumina Inc.
- Trupanion Inc.
- Price
- $261.35-2.50%
- $28.25+1.33%
- Market cap
- $41.04B
- $1.17B
- 1M return
- +6.53%
- +10.09%
- 1Y return
- +172.52%
- -33.48%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2000
- News (4w)
- 8
- 4
- Recent ratings
- 25
- 13
Illumina Inc.
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. It has a collaboration agreement with Geneseeq Technology Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits for cancer. The company was incorporated in 1998 and is headquartered in San Diego, California.
Trupanion Inc.
Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. Trupanion, Inc. was founded in 2000 and is headquartered in Seattle, Washington.
Latest ILMN
- Illumina launches BioInsight Platform, its first unified software environment to help accelerate genomic and multiomic breakthroughs
- SEC Form 8-K filed by Illumina Inc.
- Illumina to Announce Third Quarter 2026 Financial Results on Thursday, October 29, 2026
- Illumina releases SpliceAI2 to help advance rare disease research
- SEC Form 4 filed by Illumina Inc.
- SEC Form SCHEDULE 13G filed by Illumina Inc.
- Director Meister Keith A. was granted 107 shares, increasing direct ownership by 2% to 6,887 units (SEC Form 4)
- Director Ullem Scott B. was granted 113 shares, increasing direct ownership by 1% to 11,143 units (SEC Form 4)
- Chief Legal Officer Coletti Julie Ann was granted 18,763 shares (SEC Form 4)
- SVP, Chief Technology Officer Barnard Steven covered exercise/tax liability with 408 shares, decreasing direct ownership by 0.99% to 40,927 units (SEC Form 4)
Latest TRUP
- Picture Purrfect Pets: Trupanion Announces 2026 truFame Winners
- SEC Form 4 filed by Trupanion Inc.
- A Partnership for Pets: Simon Cowell and Trupanion Team Up
- Chief Operating Officer Gallagher John R sold $9,879 worth of shares (431 units at $22.92) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 33,311 units (SEC Form 4)
- CEO Tooth Margaret sold $25,000 worth of shares (1,000 units at $25.00) as part of a pre-agreed trading plan, decreasing direct ownership by 0.53% to 185,952 units (SEC Form 4)
- Trupanion Searches for this Year’s “It Pets” With Return of Annual truFame Contest
- Chief Operating Officer Gallagher John R sold $107,039 worth of shares (3,604 units at $29.70) as part of a pre-agreed trading plan, decreasing direct ownership by 10% to 33,742 units (SEC Form 4)
- CEO Tooth Margaret converted options into 19,042 shares, covered exercise/tax liability with 7,000 shares and sold $15,633 worth of shares (491 units at $31.84), increasing direct ownership by 7% to 186,952 units (SEC Form 4) (withholding tax)
- Director Rubin Howard E converted options into 420 shares, increasing direct ownership by 0.18% to 233,288 units (SEC Form 4)
- Director Powell Bradley S converted options into 1,640 shares, increasing direct ownership by 86% to 3,546 units (SEC Form 4)